Top

The International Journal of Cardiovascular Imaging

Published in:

Open Access 01-09-2019 | Atrial Fibrillation | Original Paper

Left atrial longitudinal strain by speckle tracking as independent predictor of recurrence after electrical cardioversion in persistent and long standing persistent non-valvular atrial fibrillation

Authors: Luis Antonio Moreno-Ruiz, Alejandra Madrid-Miller, Jerónimo Enrique Martínez-Flores, Jesús Antonio González-Hermosillo, Jorge Arenas-Fonseca, Noé Zamorano-Velázquez, Beatriz Mendoza-Pérez

Published in: The International Journal of Cardiovascular Imaging | Issue 9/2019

Abstract

Atrial fibrillation (AF) is the most common arrhythmia in humans. After successful cardioversion, there is a recurrence of 60% due to atrial remodeling, and it has been shown that the global peak atrial longitudinal strain (GPALS) is decreased in these subjects. The aim of this study was to evaluate the predictive value of GPALS for AF recurrence. A prospective cohort of patients with persistent (PnVAF) and long standing persistent non-valvular AF (LSPnVAF) which underwent electrical cardioversion was evaluated with standard echocardiographic variables and GPALS quantification. The primary endpoint was AF recurrence at 6 months. We included PnVAF (n = 50, aged 68.4 ± 10.2 years, female 46%, lasted AF 6 months) and LSPnVAF (n = 81, aged 66.5 ± 13.1 years, female 36%, lasted AF 18 months). At 6 months there were a 68% of recurrence of AF in PnVAF and 53% in LSPnVAF group. GPALS was lower in recurrence 7.8 ± 2.0% versus 21.2 ± 8.9% (p < 0.001) for PnVAF and 7.3 ± 2.7% versus 20.7 ± 7.6% (p < 0.001) in LSPnVAF. GPALS ≤ 10.75% discriminates recurrence at 6 months with a sensitivity of 85%, specificity 99%, PPV 85%, NPV 90%, LR + 8.5 and LR- 0.17. The independent predictors of recurrence in PnVAF were GPALS ≤ 10.75% HR 8.89 [(2.2–35.7), p < 0.01] meanwhile in LSPnVAF were age HR 1.039 [(1.007-1.071), p = 0.01], and GPALS ≤ 10.75% HR 28.1 [(7.2–109.1), p < 0.001]. In subjects with PnVAF and LSPnVAF with successful electrical cardioversion, GPALS ≤ 10.75% predicts arrhythmia recurrence at 6-month follow-up.

Camm AJ, Kirchhof P, Lip GYH, Schotten U, Savelieva I, Ernst S, Van Gelder I, Al-Attar N, Hindricks G, Prendergast B, Heidbuchel H, Afieri O, Angelini A, Atar D, Colonna P, De Caterina R, De Sutter J, Goette A, Gorenek B, Heldal M, Hohloser SH, Kolh P, Le Heuzey JY, Ponikowski P, Rutten FH, ESC Committee for Practice Guidelines (2010) Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 31:2369–2429. https://doi.org/10.1093/eurheartj/ehq278 CrossRefPubMed

Khaykin Y, Shamiss Y (2012) Costs considerations in the management of atrial fibrillation—impact of dronedarone. Clinicoecon Outcomes Res 4:67–68. https://doi.org/10.2147/CEOR.S16675 CrossRefPubMedPubMedCentral

Olivotto I, Cecchi F, Casey SA, Dolara A, Traverse JH, Maron BJ (2001) Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy. Circulation 104:2517–2524. https://doi.org/10.1161/hc4601.097997 CrossRefPubMed

Wolf PA, Mitchell JB, Baker CS, Kannel WB, D’Agostino RB (1998) Impact of atrial fibrillation on mortality, stroke, and medical costs. Arch Intern Med 158:229–234. https://doi.org/10.1001/archinte.158.3.229 CrossRefPubMed

Benjamin EJ, Wolf PA, D’Agostino RB, Silbershatz H, Kannel WB, Levy D (1998) Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 98:946–952. https://doi.org/10.1161/01.CIR.98.10.946 CrossRefPubMed

Ringborg A, Nieuwlaat R, Lindgren P, Jönsson B, Fidan D, Maggioni A, Lopez-Sendon J, Stepinska J, Cokkinos DV, Crijns HJGM (2008) Costs of atrial fibrillation in five European countries: results from the Euro Heart Survey on atrial fibrillation. Europace 10:403–411. https://doi.org/10.1093/europace/eun048 CrossRefPubMed

Wolowacz SE, Samuel M, Brennan VK, Jasso-Mosqueda JG, Van Gelder IC (2011) The cost of illness of atrial fibrillation: a systematic review of the recent literature. Europace 13:1375–1385. https://doi.org/10.1093/europace/eur194 CrossRefPubMed

Guía de práctica clínica, diagnóstico y tratamiento de la fibrilación auricular (2012) México: Secretaría de Salud. Rev Med Inst Mex Seguro Soc 50:213–231

January CT, Wann S, Alpert JS, Calkins H, Cleveland JC, Cigarroa JE, Conti JB, Ellinor PT, Ezekowitz MD, Field ME, Murray KT, Sacco RL, Stevenson WG, Tchou PJ, Tracy CM, Yancy CW (2014) AHA/SCC/HRS Guideline for the management of patients with atrial fibrillation. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 64:2246–2280. https://doi.org/10.1016/j.jacc.2014.03.021 CrossRef

10.

Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Kay GN, Le Huezey JY, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann LS (2011) ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in partnership wit the European Society of Cardiology and in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. J Am Coll Cardiol 57:e101–e198. https://doi.org/10.1016/j.jacc.2010.09.13 CrossRefPubMed

11.

Camm AJ, Savelieva I (2012) Atrial fibrillation: the rate versus the rhythm management controversy. J R Coll Phys Edinb 42:23–34. https://doi.org/10.4997/jrcpe.2012.s03 CrossRef

12.

Kato T, Yamashita T, Sagara K, Iinuma H, Fu LT (2004) Progressive nature of paroxysmal atrial fibrillation. Observations of 14-year follow up study. Circ J 68:568–572. https://doi.org/10.1253/circj.68.568 CrossRefPubMed

13.

Moreno-Ruíz LA, Rodríguez-Piña H, Martínez-Enríquez JE (2012) Fibrilación auricular. Evaluación y tratamiento. Rev Med Inst Mex Seguro Soc 50:273–284PubMed

14.

Sopher SM, Camm AJ (1996) Atrial fibrillation: maintenance sinus rhythm versus rate control. Am J Cardiol 77:24A–37A. https://doi.org/10.1016/S0002-9149(97)89115-1 CrossRefPubMed

15.

Casaclang-Verzosa G, Gersh BJ, Tsang TSM (2008) Structural and functional remodeling of the left atrium. Clinical and therapeutic implications for atrial fibrillation. J Am Coll Cardiol 51:1–11CrossRefPubMed

16.

Nattel S (1999) Electrophysiologic remodeling: are ion channels static players or dynamic movers? J Cardiovasc Electrophysiol 10:1553–1556. https://doi.org/10.1111/j.1540-8167.1999.tb00214.x CrossRefPubMed

17.

Goette A, Honeycutt C, Langberg JJ (1996) Electrical remodeling in atrial fibrillation. Time course and mechanisms. Circulation 94:2968–2974. https://doi.org/10.1161/01.CIR.94.11.2968 CrossRefPubMed

18.

Ausma J, Litjens N, Lenders MH, Duimel H, Mast F, Wouters L, Ramaekers F, Allesie M, Borgers M (2001) Time course of atrial fibrillation-induced cellular structural remodeling in atria of the goat. J Mol Cell Cardiol 33:2083–2094. https://doi.org/10.1006/jmcc.2001.1472 CrossRefPubMed

19.

Li DS, Fareh S, Leung TK, Nattel S (1999) Promotion of atrial fibrillation by heart failure in dogs—atrial remodeling of a different sort. Circulation 100:87–95. https://doi.org/10.1161/01.CIR.100.1.87 CrossRefPubMed

20.

Burstein B, Nattel S (2008) Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation. J Am Coll Cardiol 51:802–809. https://doi.org/10.1016/j.jacc.2007.09.064 CrossRefPubMed

21.

Everett TH, Olgin JE (2007) Atrial fibrosis and the mechanisms of atrial fibrillation. Heart Rhythm 4:S24–S27. https://doi.org/10.1016/j.hrthm.2006.12.040 CrossRefPubMed

22.

Tan AY, Zimetbaum P (2011) Atrial fibrillation and atrial fibrosis. J Cardiovasc Pharmacol 57:373–375. https://doi.org/10.1097/FJC.0b013e3182073c78 CrossRef

23.

Shelton RJ, Kaye GC, Cleland JGF (2004) Controlling persistent atrial fibrillation. QJM 97:179–180. https://doi.org/10.1093/qjmed/hch033 CrossRefPubMed

24.

Kim SK, Pak HN, Park JH, Ko KJ, Lee JS, Choi JI, Choi DH, Kim YH (2009) Clinical and serological predictors for the recurrence of atrial fibrillation after electrical cardioversion. Europace. https://doi.org/10.1093/europace/eup321 CrossRefPubMed

25.

Madrid AH, Bueno MG, Rebollo JMG, Marín I, Peña G, Bernal E, Rodriguez A, Cano L, Cano JM, Cabeza P, Moro C (2002) Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation a prospective and randomized study. Circulation 106:331–336. https://doi.org/10.1161/01.CIR.0000022665.18619.83 CrossRefPubMed

26.

Fogari R, Mugellini A, Destro M, Corradi L, Zoppi A, Fogari E, Rinaldi A (2006) Losartan and prevention of atrial recurrence in hypertensive patients. J Cardiovasc Pharmacol 47:46–50. https://doi.org/10.1097/01.fjc.0000193808.99773.28 CrossRefPubMed

27.

Fogari R, Zoppi A, Maffioli P, Mugellini A, Pretti P, Perrone T (2012) Effect of telmisartan on paroxysmal atrial fibrillation recurrence in hypertensive patients with normal or increased left atrial size. Clin Cardiol 35:359–364. https://doi.org/10.1002/clc.21994 CrossRefPubMedPubMedCentral

28.

Healey JS, Baranchuk A, Crystal E, Morillo CA, Garfinkle M, Yusuf S, Connolly SJ (2005) Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers. A meta-analysis. J Am Coll Cardiol 45:1832–1839. https://doi.org/10.1016/j.jacc.2004.11.070 CrossRefPubMed

29.

Disertori M, Barlera S, Staszewsky L, Latini R, Quintarelli S, Franzosi M (2012) Systematic review and metaanalysis: renin-angiotensin system inhibitors in the prevention of atrial fibrillation recurrences: an unfulfilled hope. Cardiovasc Drugs Ther 1:47–54. https://doi.org/10.1007/s10557-011-6346-0 CrossRef

30.

Ökçün B, Yigit Z, Küçükoglu MS, Mutlu H, Sansoy V, Güzelsoy D, Üner S (2002) Predictors for maintenance of sinus rhythm after cardioversion in patients with nonvalvular atrial fibrillation. Echocardiography 19:351–357. https://doi.org/10.1046/j.1540-8175.2002.00351.x CrossRefPubMed

31.

Antonielli E, Pizzuti A, Pálinkás A, Tanga M, Gruber M, Michelassi C, Varga A, Bonzano A, Gandolfo N, Halmai L, Bassignana A, Imran MB, Deln Evo F, Csanády M, Picano E (2002) Clinical value of left atrial appendage flow for prediction of long-term sinus rhythm maintenance in patients with nonvalvular atrial fibrillation. J Am Coll Cardiol 39:1443–1449CrossRefPubMed

32.

Marchese P, Bursi F, Delle Donne G, Malavasi V, Casali E, Barbieri A, Melandri F, Modena MG (2011) Indexed left atrial volume predicts de recurrence of non-valvular atrial fibrillation after successful cardioversion. Eur J Echocardiogr 12:214–221. https://doi.org/10.1093/ejechocard/jeq176 CrossRefPubMed

33.

Marchese P, Malavasi V, Rossi L, Nikolskaya N, Delle Donne G, Becirovic M, Colantoni A, Luciani A, Modena MG (2012) Indexed left atrial volume is superior to left atrial diameter in predicting non valvular atrial fibrillation recurrence after successful cardioversion: a prospective study. Echocardiograpy 3:276–284. https://doi.org/10.1111/j.1540-8175.2011.01580.x CrossRef

34.

Ahmed MK, Abdelazez WF, Nasif MA (2015) Assesment of left atrium mechanical function by deformation imaging in atrial fibrillation and its correlation with CHA2DS2-Vasc risk score. Egypt Heart J 67:209–215. https://doi.org/10.1016/j.ehj.2014.08.001 CrossRef

35.

D’Ascenzo F, Corieto A, Biondi-Zoccal G, Anselmino M, Ferraris F, Di Biase L, Natale A, Hunter RJ, Schilling RJ, Miyazaki S, Tada H, Aonuma K, Yenn-Jiang L, Tao H, Ma C, Packer D, Hammill S, Gaita F (2013) Which are the most reliable predictors of recurrence of atrial fibrillation afer transcatheter ablation?: a meta-analysis. Int J Cardiol 167:1984–1989. https://doi.org/10.1016/j.ijcard.2012.05.008 CrossRefPubMed

36.

Blume GG, Mcleod CJ, Barnes ME, Seward JB, Pellikka PA, Bastiansen PM, Tsang TSM (2011) Left atrial function: physiology, assessment, and clinical implications. Eur J Echocardiogr 12:421–430. https://doi.org/10.1093/ejechocard/jeq175 CrossRefPubMed

37.

Wang T, Wang M, Fung JWH, Yip GWK, Zhang Y, Ho PPY, Tse DMK, Yu CM, Sanderson JE (2007) Atrial strain echocardiography can predict success or failure of cardioversion for atrial fibrillation: a combined transthoracic tissue Doppler and transesophageal imaging study. Int J Cardiol 114:202–209. https://doi.org/10.1016/j.ijcard.2006.01.051 CrossRefPubMed

38.

Geyer H, Caracciolo G, Abe H, Wilansky S, Carerj S, Gentile F, Nesser HJ, Khandheria B, Narula J, Sengupta P (2010) Assesment of myocardial mechanics using speckle tracking echocardiography: fundamentals and clinical applications. J Am Soc Echocardiogr 23:351–369. https://doi.org/10.1016/j.echo.2010.02.015 CrossRefPubMed

39.

Pinto M (2011) Strain: una ventana a la mecánica ventricular. Rev Chil Cardiol 31:155–159. https://doi.org/10.4067/S0718-85602011000200009 CrossRef

40.

Langeland S, D’hooge J, Wouters PF, Leather HA, Claus P, Bijnens B, Sutherland GR (2005) Experimental validation of a new ultrasound method for the simultaneous assessment of radial and longitudinal myocardial deformation independent of insonation angle. Circulation 112:2157–2162. https://doi.org/10.1161/CIRCULATIONAHA.105.554006 CrossRefPubMed

41.

Cameli M, Caputo M, Mondillo S, Ballo P, Palmerini E, Lisi M, Marino E, Galderisi M (2009) Feasibility and reference values of left atrial longitudinal strain imaging by two dimensional speckle tracking. Cardiovasc Ultrasound 7:1–6. https://doi.org/10.1186/1476-7120-7-6 CrossRef

42.

Cameli M, Lisi M, Focardi M, Reccia R, Natali BM, Sparla S, Mondillo S (2012) Left atrial deformation analysis by speckle tracking echocardiography for prediction of cardiovascular outcomes. Am J Cardiol 110:264–269. https://doi.org/10.1016/j.amjcard.2012.03.022 CrossRefPubMed

43.

Kuppahally SS, Akoum N, Burgon NS, Badger TJ, Kholmovski EG, Vijayakumar S, Rao SN, Blauer J, Fish EN, DiBella EVR, MacLeod RS, McGann C, Ltwin SE, Marrouche NF (2010) Left atrial strain and strain rate in patients with paroxysmal and persistent atrial fibrillation. Relationship to left atrial structural remodeling detected by delayed-enhancement MRI. Circ Cardiovasc Imaging 3:231–239. https://doi.org/10.1161/CIRCIMAGING.109.865683 CrossRefPubMed

44.

Cameli M, Lisi M, Righini FM, Massoni A, Natali BM, Focardi M, T’Acchini D, Geyer A, Curci V, Di Tommaso C, Lisi G, Maccherini M, Chiavarelli M, Massetti M, Tanganeli P, Mondillo S (2013) Usefulness of atrial deformation analysis to predict left atrial fibrosis and endocardial thickness in patients undergoing mitral valve operations for severe mitral regurgitation secondary to mitral valve prolapse. Am J Cardiol 111:595–601. https://doi.org/10.1016/j.amjcard.2012.10.049 CrossRefPubMed

45.

Dell’Era G, Rondano E, Franchi E, Marino PM (2010) Atrial asynchrony and function before and after electrical cardioversion for persistent atrial fibrillation. Eur J Echocardiogr 11:577–583. https://doi.org/10.1093/ejechocard/jeq010 CrossRefPubMed

46.

Motoki H, Negishi K, Kusunose K, Popovic ZB, Bhagarva M, Wazni O, Saliba WI, Chung MK, Marwick TH, Klein AL (2014) Global left atrial strain in the prediction of sinus rhythm maintenance after catheter ablation for atrial fibrillation. J Am Soc Echocardiogr 27:1184–1192. https://doi.org/10.1016/j.echo.2014.08.017 CrossRefPubMedPubMedCentral

47.

Harada M, Van Wagoner D, Nattel S (2015) Role of inflammation in atrial fibrillation pathophysiology and management. Circ J 79:495–502. https://doi.org/10.1253/circj.CJ-15-0318 CrossRefPubMedPubMedCentral

48.

Hu YF, Chen YJ, Lin YJ, Chen SA (2015) Inflammation and the pathogenesis of atrial fibrillation. Nat Rev Cardiol 12:230–243. https://doi.org/10.1038/nrcardio.2015.2 CrossRefPubMed

Title: Left atrial longitudinal strain by speckle tracking as independent predictor of recurrence after electrical cardioversion in persistent and long standing persistent non-valvular atrial fibrillation
Authors: Luis Antonio Moreno-Ruiz
Alejandra Madrid-Miller
Jerónimo Enrique Martínez-Flores
Jesús Antonio González-Hermosillo
Jorge Arenas-Fonseca
Noé Zamorano-Velázquez
Beatriz Mendoza-Pérez
Publication date: 01-09-2019
Publisher: Springer Netherlands
Keyword: Atrial Fibrillation
Published in: The International Journal of Cardiovascular Imaging / Issue 9/2019
Print ISSN: 1569-5794
Electronic ISSN: 1875-8312
DOI: https://doi.org/10.1007/s10554-019-01597-7

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Left atrial longitudinal strain by speckle tracking as independent predictor of recurrence after electrical cardioversion in persistent and long standing persistent non-valvular atrial fibrillation

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 9/2019

CT-derived left ventricular global strain: a head-to-head comparison with speckle tracking echocardiography

Procedure planning and device positioning for left atrial appendage occlusion: insights from multi detector-row computed tomography with 3D fusion

Simultaneous evaluation of plaque stability and ischemic potential of coronary lesions in a fluid–structure interaction analysis

Effect of diastolic dysfunction on intraventricular velocity behavior in early diastole by flow mapping

Hemodynamic impact of coronary stenosis using computed tomography: comparison between noninvasive fractional flow reserve and 3D fusion of coronary angiography with stress myocardial perfusion

The effect of contrast agents on left ventricular parameters calculated by a threshold-based software module: does it truly matter?

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page